1. Roy R, Alotaibi AA, Freedman MS. Sphingosine 1-phosphate receptor modulators for multiple sclerosis. CNS Drugs. 2021;35(4):385–402.
2. Novartis Pharmaceuticals Corporation. GILENYA (fingolimod) capsules [package insert]. Food and Drug Administration; 2012.
3. Novartis Pharmaceuticals Corporation. MAYZENT® (siponimod) tablets, for oral use [package insert]. Food and Drug Administration; 2019.
4. Celgene Corporation. ZEPOSIA® (ozanimod) capsules, for oral use [package insert]. Food and Drug Administration; 2020.
5. Janssen Pharmaceuticals. PONVORY™ (ponesimod) tablets, for oral use [package insert]. Food and Drug Administration; 2021.